| A clinical trial to maintain glycemic control in youth with type 2 diabetes TODAY Study Group New England Journal of Medicine 366 (24), 2247-2256, 2012 | 985 | 2012 |
| Lutein plus Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration The Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial EY Chew, TE Clemons, JP SanGiovanni, R Danis, FL Ferris III, M Elman, ... JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 309 (19), 2005-2015, 2013 | 820* | 2013 |
| The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1) EY Chew, T Clemons, JP SanGiovanni, R Danis, A Domalpally, W McBee, ... Ophthalmology 119 (11), 2282-2289, 2012 | 427 | 2012 |
| Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3 EY Chew, TE Clemons, JP SanGiovanni, RP Danis, FL Ferris, MJ Elman, ... JAMA ophthalmology 132 (2), 142-149, 2014 | 425 | 2014 |
| Long-term effects of ranibizumab on diabetic retinopathy severity and progression MS Ip, A Domalpally, JJ Hopkins, P Wong, JS Ehrlich Archives of ophthalmology 130 (9), 1145-1152, 2012 | 271 | 2012 |
| Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the Eye (HOME) study EY Chew, TE Clemons, SB Bressler, MJ Elman, RP Danis, A Domalpally, ... Ophthalmology 121 (2), 535-544, 2014 | 226 | 2014 |
| Long-term effects of therapy with ranibizumab on diabetic retinopathy severity and baseline risk factors for worsening retinopathy MS Ip, A Domalpally, JK Sun, JS Ehrlich Ophthalmology 122 (2), 367-374, 2015 | 223 | 2015 |
| Progression of geographic atrophy in age-related macular degeneration: AREDS2 report number 16 TD Keenan, E Agrón, A Domalpally, TE Clemons, F van Asten, WT Wong, ... Ophthalmology 125 (12), 1913-1928, 2018 | 167 | 2018 |
| Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4 EY Chew, JP SanGiovanni, FL Ferris, WT Wong, E Agron, TE Clemons, ... JAMA ophthalmology 131 (7), 843-850, 2013 | 162 | 2013 |
| Pivotal evaluation of an artificial intelligence system for autonomous detection of referrable and vision-threatening diabetic retinopathy E Ipp, D Liljenquist, B Bode, VN Shah, S Silverstein, CD Regillo, JI Lim, ... JAMA network open 4 (11), e2134254-e2134254, 2021 | 120 | 2021 |
| Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2) RP Danis, A Domalpally, EY Chew, TE Clemons, J Armstrong, ... Investigative ophthalmology & visual science 54 (7), 4548-4554, 2013 | 118 | 2013 |
| Geographic atrophy in patients with advanced dry age-related macular degeneration: current challenges and future prospects RP Danis, JA Lavine, A Domalpally Clinical Ophthalmology, 2159-2174, 2015 | 100 | 2015 |
| Prevalence, risk, and genetic association of reticular pseudodrusen in age-related macular degeneration: age-related eye disease study 2 report 21 A Domalpally, E Agrón, JW Pak, TD Keenan, FL Ferris III, TE Clemons, ... Ophthalmology 126 (12), 1659-1666, 2019 | 85 | 2019 |
| Effects of intravitreal ranibizumab on retinal hard exudate in diabetic macular edema: findings from the RIDE and RISE phase III clinical trials A Domalpally, MS Ip, JS Ehrlich Ophthalmology 122 (4), 779-786, 2015 | 83 | 2015 |
| Circularity index as a risk factor for progression of geographic atrophy A Domalpally, RP Danis, J White, A Narkar, T Clemons, F Ferris, E Chew Ophthalmology 120 (12), 2666-2671, 2013 | 83 | 2013 |
| Peripheral retinal changes associated with age-related macular degeneration in the age-related eye disease study 2: age-related eye disease study 2 report number 12 by the age … TWC for the OPTOS, A Domalpally, TE Clemons, RP Danis, SVR Sadda, ... Ophthalmology 124 (4), 479-487, 2017 | 81 | 2017 |
| Long-term outcomes of adding lutein/zeaxanthin and ω-3 fatty acids to the AREDS supplements on age-related macular degeneration progression: AREDS2 report 28 EY Chew, TE Clemons, E Agrón, A Domalpally, TDL Keenan, S Vitale, ... JAMA ophthalmology 140 (7), 692-698, 2022 | 75 | 2022 |
| Prevalence and severity of artifacts in optical coherence tomographic angiograms IC Holmen, SM Konda, JW Pak, KW McDaniel, B Blodi, KE Stepien, ... JAMA ophthalmology 138 (2), 119-126, 2020 | 68 | 2020 |
| Insulin sensitivity and diabetic kidney disease in children and adolescents with type 2 diabetes: an observational analysis of data from the TODAY clinical trial P Bjornstad, E Nehus, F Bacha, IM Libman, S McKay, SM Willi, L Laffel, ... American Journal of Kidney Diseases 71 (1), 65-74, 2018 | 66 | 2018 |
| Randomized trial of the ForeseeHome monitoring device for early detection of neovascular age-related macular degeneration. The HOme Monitoring of the Eye (HOME) study design … EY Chew, TE Clemons, SB Bressler, MJ Elman, RP Danis, A Domalpally, ... Contemporary clinical trials 37 (2), 294-300, 2014 | 66 | 2014 |
